ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
Praetorian2011
|
13 |
5.6K |
2 |
21/07/25 |
21/07/25 |
ASX - By Stock
|
13
|
5.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Praetorian2011
|
444 |
193K |
0 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
444
|
193K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Praetorian2011
|
444 |
193K |
3 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
444
|
193K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Proposed Consolidation of Capital
|
|
Praetorian2011
|
516 |
205K |
0 |
17/05/25 |
17/05/25 |
ASX - By Stock
|
516
|
205K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Proposed Consolidation of Capital
|
|
Praetorian2011
|
516 |
205K |
0 |
17/05/25 |
17/05/25 |
ASX - By Stock
|
516
|
205K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
|
|
Praetorian2011
|
272 |
111K |
2 |
15/05/25 |
15/05/25 |
ASX - By Stock
|
272
|
111K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Letter to Shareholders
|
|
Praetorian2011
|
259 |
113K |
52 |
01/05/25 |
01/05/25 |
ASX - By Stock
|
259
|
113K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Gregory George
|
|
Praetorian2011
|
29 |
15K |
0 |
24/04/25 |
24/04/25 |
ASX - By Stock
|
29
|
15K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
|
|
Praetorian2011
|
164 |
51K |
5 |
04/04/25 |
04/04/25 |
ASX - By Stock
|
164
|
51K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
|
|
Praetorian2011
|
164 |
51K |
4 |
04/04/25 |
04/04/25 |
ASX - By Stock
|
164
|
51K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Meeting Requested with FDA on Revascor Accelerated Approval
|
|
Praetorian2011
|
129 |
56K |
7 |
03/04/25 |
03/04/25 |
ASX - By Stock
|
129
|
56K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Pricing Set and Available This Quarter
|
|
Praetorian2011
|
575 |
192K |
6 |
27/02/25 |
27/02/25 |
ASX - By Stock
|
575
|
192K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
Praetorian2011
|
523 |
273K |
3 |
27/02/25 |
27/02/25 |
ASX - By Stock
|
523
|
273K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Pricing Set and Available This Quarter
|
|
Praetorian2011
|
575 |
192K |
2 |
27/02/25 |
27/02/25 |
ASX - By Stock
|
575
|
192K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast 2025: The year of acting like a publicly listed company
|
|
Praetorian2011
|
1.4K |
548K |
1 |
14/01/25 |
14/01/25 |
ASX - By Stock
|
1.4K
|
548K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH
|
|
Praetorian2011
|
612 |
251K |
6 |
14/01/25 |
14/01/25 |
ASX - By Stock
|
612
|
251K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH
|
|
Praetorian2011
|
612 |
251K |
0 |
14/01/25 |
14/01/25 |
ASX - By Stock
|
612
|
251K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH
|
|
Praetorian2011
|
612 |
251K |
2 |
14/01/25 |
14/01/25 |
ASX - By Stock
|
612
|
251K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Praetorian2011
|
392 |
241K |
2 |
10/01/25 |
10/01/25 |
ASX - By Stock
|
392
|
241K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Praetorian2011
|
392 |
241K |
2 |
10/01/25 |
10/01/25 |
ASX - By Stock
|
392
|
241K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Praetorian2011
|
113 |
70K |
0 |
10/01/25 |
10/01/25 |
ASX - By Stock
|
113
|
70K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Praetorian2011
|
113 |
70K |
0 |
10/01/25 |
10/01/25 |
ASX - By Stock
|
113
|
70K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Praetorian2011
|
113 |
70K |
2 |
10/01/25 |
10/01/25 |
ASX - By Stock
|
113
|
70K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Praetorian2011
|
113 |
70K |
9 |
10/01/25 |
10/01/25 |
ASX - By Stock
|
113
|
70K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Chart
|
|
Praetorian2011
|
429 |
185K |
24 |
07/01/25 |
07/01/25 |
ASX - By Stock
|
429
|
185K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Bloomberg Interview
|
|
Praetorian2011
|
272 |
108K |
12 |
07/01/25 |
07/01/25 |
ASX - By Stock
|
272
|
108K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Bloomberg Interview
|
|
Praetorian2011
|
272 |
108K |
18 |
07/01/25 |
07/01/25 |
ASX - By Stock
|
272
|
108K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Bloomberg Interview
|
|
Praetorian2011
|
272 |
108K |
7 |
07/01/25 |
07/01/25 |
ASX - By Stock
|
272
|
108K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Bloomberg Interview
|
|
Praetorian2011
|
272 |
108K |
5 |
07/01/25 |
07/01/25 |
ASX - By Stock
|
272
|
108K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Bloomberg Interview
|
|
Praetorian2011
|
272 |
108K |
2 |
07/01/25 |
07/01/25 |
ASX - By Stock
|
272
|
108K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Praetorian2011
|
582 |
260K |
12 |
05/01/25 |
05/01/25 |
ASX - By Stock
|
582
|
260K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Praetorian2011
|
2.0K |
950K |
3 |
05/01/25 |
05/01/25 |
ASX - By Stock
|
2.0K
|
950K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
Praetorian2011
|
2.4K |
1.0M |
1 |
05/01/25 |
05/01/25 |
ASX - By Stock
|
2.4K
|
1.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast 2025: The year of acting like a publicly listed company
|
|
Praetorian2011
|
1.4K |
548K |
1 |
05/01/25 |
05/01/25 |
ASX - By Stock
|
1.4K
|
548K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast 2025: The year of acting like a publicly listed company
|
|
Praetorian2011
|
1.4K |
548K |
4 |
05/01/25 |
05/01/25 |
ASX - By Stock
|
1.4K
|
548K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Praetorian2011
|
2.0K |
950K |
11 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
2.0K
|
950K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Praetorian2011
|
2.0K |
950K |
10 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
2.0K
|
950K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Praetorian2011
|
2.0K |
950K |
4 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
2.0K
|
950K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Praetorian2011
|
582 |
260K |
13 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
582
|
260K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Praetorian2011
|
582 |
260K |
26 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
582
|
260K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Praetorian2011
|
582 |
260K |
5 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
582
|
260K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Praetorian2011
|
582 |
260K |
60 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
582
|
260K
|
60
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Praetorian2011
|
582 |
260K |
22 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
582
|
260K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Praetorian2011
|
582 |
260K |
23 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
582
|
260K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
APPRoved
|
|
Praetorian2011
|
193 |
57K |
9 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
193
|
57K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
APPRoved
|
|
Praetorian2011
|
193 |
57K |
3 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
193
|
57K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
APPRoved
|
|
Praetorian2011
|
193 |
57K |
7 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
193
|
57K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to be Added to Nasdaq Biotechnology Index
|
|
Praetorian2011
|
51 |
30K |
10 |
18/12/24 |
18/12/24 |
ASX - By Stock
|
51
|
30K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
Praetorian2011
|
16 |
9.6K |
5 |
18/12/24 |
18/12/24 |
ASX - By Stock
|
16
|
9.6K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Class Action Resolution
|
|
Praetorian2011
|
329 |
129K |
4 |
16/12/24 |
16/12/24 |
ASX - By Stock
|
329
|
129K
|
4
|
|